Five proteins (GSN, BDNF, TIMP1, VLDLR, and APLP2) were verified to be differentially expressed in AD patients vs. controls, suggesting that they might serve as potential biomarkers for AD in blood. Here, BDNF is linked to Alzheimer disease.